Skip to main content

Table 1 Eleven microarray-based miRNA expression profiling studies of human PDAC tissues

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

First author (reference)

Acronym

Region

Assay type

No. of probes

No. of samples (cancer/normal)

AE Szafranska [21]

AE

USA

Custom microarray

377

13 (8/5)

Ada Piepoli [22]

AP

Italy

Affymetrix GeneChip array

866

NR (cancer=17)

Andrea S.Bauer [23]

AS

Germany

Geniom biochip miRNA homo sapiens

NR

110 (94/16)

Eun Joo Lee [24]

EJ

USA

Agilent Human miRNA Microarray

NR

28 (15/13)

Mark Bloomston [25]

MB

USA

Custom miRNA microarray

1100

130 (65/65), 65 pairs

Nicolai A.Schultz [26]

NA

Denmark

TaqMan array human microRNA A+B Cards v2.0

664

188 (160/28)

Nigel B.Jamieson [27]

NB

USA

Agilent Human miRNA Microarray (version 2.0)

723

58 (48/10)

Nicole C.Panarelli [28]

NC

USA

FlexmiR miRNA microarray

328

27 (17/10)

S Ali [29]

SA

USA

LC Science Houston microarray

NR

44 (29/15)

Shuyu Zhang [30]

SZ

China

Exiqon miRCURY LNA array

1200

40 (20/20), 20 pairs

Yuichi Nagao [31]

YN

Japan

Toray 3D-Gene miRNA microarray

>900

79 (65/24)

  1. Abbreviations: NR not reported, pairs, cancerous and normal samples from the same patient.